Goodman Financial Corp Gilead Sciences, Inc. Transaction History

Goodman Financial Corp

$433 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $756,038 - $863,590	12,698 Added 9.19%	150,859 $9.31 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $282,019 - $317,638	4,886 Added 3.67%	138,161 $8.54 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $199,766 - $250,328	3,449 Added 2.66%	133,275 $7.92 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $275,156 - $312,307	4,241 Added 3.38%	129,826 $9.43 Million
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $318,007 - $343,094	4,698 Added 3.89%	125,585 $8.77 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $651,265 - $711,600	10,261 Added 9.28%	120,887 $8.32 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $578,100 - $659,612	9,635 Added 9.54%	110,626 $7.15 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $346,811 - $395,175	6,122 Added 6.45%	100,991 $5.88 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $91,535 - $115,089	1,474 Added 1.58%	94,869 $6 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $20,978 - $24,360	-290 Reduced 0.31%	93,395 $7.19 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $36,450 - $46,688	-582 Reduced 0.62%	93,685 $7 Million
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $62,359 - $68,593	1,012 Added 1.09%	94,267 $6.13 Million
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $92,764 - $102,396	1,484 Added 1.62%	93,255 $5.91 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $198,973 - $223,126	3,216 Added 3.63%	91,771 $6.2 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $148,196 - $166,018	2,370 Added 2.75%	88,555 $5.76 Million
Q4 2018 Feb 04, 2019	BUY	$60.54 - $79.0 $37,171 - $48,506	614 Added 0.72%	86,185 $5.39 Million
Q3 2018 Nov 02, 2018	BUY	$71.28 - $78.92 $45,476 - $50,350	638 Added 0.75%	85,571 $6.61 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $367,091 - $428,197	5,658 Added 7.14%	84,933 $6.02 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $5.77 Million - $7.04 Million	79,275 New	79,275 $5.98 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Financial Corp with notifications on news.

Account